SCHEMBL17322841

SCHEMBL17322841

COC(=O)Cn1nc(-c2cccc(OCc3ccccc3)c2F)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ MAPT P10636 2/20 0.45
▸ TSHR P16473 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ PTGER1 P34995 2/20 0.39
▸ SGMS2 Q8NHU3 2/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ F2RL3 Q96RI0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15631873 0.91 KDM4E (0.64) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17322836 0.89 LMNA (0.59) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17326651 0.86 KDM4E (0.55) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17322846 0.83 KDM4E (0.65) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17322866 0.82 KDM4E (0.63) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17322838 0.82 ALDH1A1 (0.57) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17322837 0.80 KDM4E (0.69) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL15631848 0.80 KDM4E (0.69) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL15631859 0.79 ALDH1A1 (0.74) LMNAKDM4EALDH1A1HPGDHTT
SCHEMBL17322844 0.78 KMT2A (0.58) LMNAKDM4EALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF CYP11B1, HSP90B1, CYP1B1 LMNA 3513/4885KDM4E 4525/4885ALDH1A1 1340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback